Terminated OBSERVATIONAL NCT01663974

Evaluation of Sub-syndromal Symptoms After Acute Depressive Episode in Bipolar Disorder (POLARIS)

Sponsor: AstraZeneca

Conditions Bipolar Disorder Sub-syndromal Symptoms

Updated 7 times since 2017 Last updated: Mar 6, 2015 Started: Apr 30, 2013 Primary completion: Dec 31, 2013 Completion: Dec 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

Other terminated trials from AstraZeneca

See all terminations from AstraZeneca

Other Bipolar Disorder trials with similar outcome

Browse all Bipolar Disorder trials

This observational or N/A phase trial investigates Bipolar Disorder and Sub-syndromal Symptoms and is currently terminated or withdrawn. AstraZeneca leads this study, which shows 7 recorded versions since 2013 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Terminated
Sep 2024 — Sep 2025 [monthly]

Terminated
Jul 2024 — Sep 2024 [monthly]

Terminated
Jan 2021 — Jul 2024 [monthly]

Terminated
Jun 2018 — Jan 2021 [monthly]

Terminated

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Terminated

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Terminated NA

First recorded

Apr 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

AstraZeneca

Data source: AstraZeneca

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aix-en-Provence, France , Ajaccio, France , Altkirch, France , Armentières, France , Avignon, France , Bailleul, France , Bohars, France , Bordeaux, France , Bourg-en-Bresse, France , Brest, France and 76 more locations